Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Richard Wyse
Cure Parkinson's
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
507
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Phase II, Randomized, Double-Blinded, Placebo-Controlled Trial of Liraglutide in Parkinson's Disease
Number of pages: 32
Posted: 12 Sep 2022
Elliot Hogg
,
Tina Wu
,
Catherine Bresee
,
Jeffrey Wertheimer
,
Camille Malatt
,
Echo Tan
,
Hayley Pomeroy
,
Miriam Nuno
, Richard Wyse and
Michele Tagliati
Cedars Sinai Medical Center - Department of Neurology, Cedars Sinai Medical Center - Department of Neurology, Cedars Sinai Medical Center - Biostatistics Core, Cedars Sinai Medical Center - Department of Physical Medicine and Rehabilitation, Cedars Sinai Medical Center - Department of Neurology, Cedars Sinai Medical Center - Department of Neurology, Cedars Sinai Medical Center - Department of Neurology, University of California, Davis - Department of Public Health Sciences, Cure Parkinson's and Cedars Sinai Medical Center - Department of Neurology
Downloads
507
(112,186)
View PDF
Download
Abstract:
Parkinson's disease, liraglutide, glucagon-like peptide-1, clinical trial
Feedback
